Global Sarcoma
Biopsy Market, by Product Type (Reusable Device and Disposable Devices), by
End User (Hospitals, Ambulatory Surgical Centers, and Diagnostic Centers), and
by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa), was valued at US$ 192.55
million in 2019, and is expected to exhibit a CAGR of 2.8% over the
forecast period (2020-2027), as highlighted in a new report published by
Coherent Market Insights.
Global sarcoma biopsy market is
expected to witness to significant growth during the forecast period, owing to
increasing technological advancements in the field of biopsy. For instance, in
November 2015, Cook Medical launched its new EchoTip ProCore 20 gage needle
with ReCoil Stylet, which will help the physicians to collect the blood samples
from the rom difficult anatomical locations. Ecotip ProCore has core-trap
technology, which will allow the physicians to collect samples during the
minimally invasive procedure.
Furthermore, in October 2017,
European Commission approved the acquisition of C.R Bard by Becton Dickinson
Company. This acquisition helped the company to manufacture new medical devices
and technology, which will be utilized to cure many serious conditions such as
cancer.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/3819
Browse 26 Market Data Tables and
25 Figures spread through 151 Pages and in-depth TOC on Global Sarcoma Biopsy
Market, by Product Type (Reusable Device and Disposable Devices), by End User
(Hospitals, Ambulatory Surgical Centers, and Clinics), and by Region (North
America, Latin America, Europe, Asia Pacific, Middle East, and Africa)-
Forecast to 2027"
Increasing prevalence of
osteosarcoma is expected to drive growth of the global sarcoma biopsy market.
Osteosarcoma is the most common
type of cancer affecting bones, and it mostly occurs in children and young
adults. On the basis of cells, osteosarcoma is classified as high-,
intermediate- and low-grade. For instance, according to the American Cancer
Society, IN January 2020, around 800 to 900 new cases of osteosarcoma are
diagnosed in the U.S. each year, with around 50% occurs in children and
teenagers.
Global Sarcoma Biopsy Market–
Regional Analysis
North America accounted for the
largest market share in the global sarcoma biopsy market, owing to rising
healthcare expenditure in the U.S. For instance, according to the Committee for
a Responsible Federal Budget, in 2017, the U.S. spent around US $ 3.5 trillion,
or 18% of the total GDP, on health expenditures, which is more than twice the
average among developed countries.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/sarcoma-biopsy-market-3819
Key Takeaways of the Global
Sarcoma Biopsy Market:
The global sarcoma Biopsy market
is expected to exhibit a CAGR of 2.8% over the forecast period (2020-2027),
owing to increasing technological advancements in the field of biopsy.
Kaposi sarcoma being one of the
sarcoma condition is much more common among men than women, and is rarely
observed among children. For instance, according to the American Cancer Society
(ACS), February 2016 data findings, around 1 in 200 transplant patients in the
U.S. suffer from Kaposi sarcoma. In the U.S.
Major players operating in the
global sarcoma biopsy market include R. Bard, Inc., Becton, Dickinson and
Company, Argon Medical Devices, InVivo Therapeutics Corporation, Cook Medical
Incorporated, UROMED, and Sterylab
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/3819
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment